Skip to main content
Log in

Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Lymph node metastasis is common in patients with papillary thyroid cancer (PTC). Some metastatic lymph nodes may present extranodal extension (ENE). The clinical role of ENE in PTC has yet to be clearly identified. We evaluated macroscopic ENE as a potential prognostic indicator of lung metastasis in PTC.

Patients and methods

We identified 1140 consecutive patients who had PTC initially resected at our cancer center. Clinical data and pathological results were reviewed. Univariate and multivariate logistic regression analyses were used to figure out the association between clinicopathological variables and lung metastasis.

Results

In this cohort, 51.7% of PTC patients had lymph node metastasis; 10.4% had macroscopic ENE positive nodes; 2.3% had lung metastasis. In patients with lymph node metastasis, the average number of positive nodes was 5.10 ± 4.91. Multivariable analysis of clinicopathological factors revealed that extrathyroidal extension (odds ratio [OR], 3.57; 95% CI, 1.41–9.04), macroscopic ENE (OR, 7.08; 95% CI, 2.54–19.74), and number of positive nodes were significantly associated with lung metastasis. Compared with 0–3 positive nodes, 7–9 positive nodes denoted a moderate risk of lung metastasis (OR, 4.53; 95% CI, 1.03–19.85). And 10 positive nodes or more indicated a high risk of lung metastasis (OR, 9.63; 95% CI, 2.65–35.02).

Conclusion

Macroscopic ENE could serve as a strong independent prognostic factor of lungmetastasis in PTC. More attention should be paid to patients with ENE positive nodes duringfollow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. H. Park, J. Park, S.Y. Park, T.H. Kim, S.W. Kim, J.H. Chung, Clinical course from diagnosis to death in patients with well-differentiated thyroid cancer. Cancers 12(8) (2020). https://doi.org/10.3390/cancers12082323

  2. J.D. Lin, T.C. Chao, S.C. Chou, C. Hsueh, Papillary thyroid carcinomas with lung metastases. Thyroid.: Off. J. Am. Thyroid. Assoc. 14(12), 1091–1096 (2004). https://doi.org/10.1089/thy.2004.14.1091

    Article  Google Scholar 

  3. A. Machens, H. Dralle, Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. J. Clin. Endocrinol. Metab. 97(12), 4375–4382 (2012). https://doi.org/10.1210/jc.2012-1257

    Article  CAS  PubMed  Google Scholar 

  4. Y.S. Lee, Y.S. Lim, J.C. Lee, S.G. Wang, I.J. Kim, S.M. Son, B.J. Lee, Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann. surgical Oncol. 18(12), 3486–3492 (2011). https://doi.org/10.1245/s10434-011-1763-7

    Article  Google Scholar 

  5. Y.M. Park, S.G. Wang, D.H. Shin, I.J. Kim, S.M. Son, B.J. Lee, Lymph node status of lateral neck compartment in patients with N1b papillary thyroid carcinoma. Acta Oto-laryngologica 136(3), 319–324 (2016). https://doi.org/10.3109/00016489.2015.1116045

    Article  PubMed  Google Scholar 

  6. Y. Ito, T. Kudo, Y. Takamura, K. Kobayashi, A. Miya, A. Miyauchi, Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age. World J. Surg. 35(12), 2684–2690 (2011). https://doi.org/10.1007/s00268-011-1288-z

    Article  PubMed  Google Scholar 

  7. M.B. Amin, F.L. Greene, S.B. Edge, C.C. Compton, J.E. Gershenwald, R.K. Brookland, L. Meyer, D.M. Gress, D.R. Byrd, D.P. Winchester, The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA: Cancer J. Clin. 67(2), 93–99 (2017). https://doi.org/10.3322/caac.21388

    Article  Google Scholar 

  8. H.I. Kim, J. Hyeon, S.Y. Park, H.S. Ahn, K. Kim, J.M. Han, J.C. Bae, J.H. Shin, J.S. Kim, S.W. Kim, J.H. Chung, T.H. Kim, Y.L. Oh, Impact of extranodal extension on risk stratification in papillary thyroid carcinoma. Thyroid.: Off. J. Am. Thyroid. Assoc. 29(7), 963–970 (2019). https://doi.org/10.1089/thy.2018.0541

    Article  CAS  Google Scholar 

  9. M.E. Rowe, U. Ozbek, R.A. Machado, L.E. Yue, J.C. Hernandez-Prera, A. Valentino, M. Qazi, M. Brandwein-Weber, X. Liu, B.M. Wenig, M.L. Urken, The prevalence of extranodal extension in papillary thyroid cancer based on the size of the metastatic node: adverse histologic features are not limited to larger lymph nodes. Endocr. Pathol. 29(1), 80–85 (2018). https://doi.org/10.1007/s12022-018-9518-7

    Article  PubMed  Google Scholar 

  10. J.L. Roh, J.W. Park, J. Jeong, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam, S.Y. Kim, Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J. Surgical Oncol. 116(4), 450–458 (2017). https://doi.org/10.1002/jso.24713

    Article  CAS  Google Scholar 

  11. J.W. Kim, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam, S.Y. Kim, Extent of extrathyroidal extension as a significant predictor of nodal metastasis and extranodal extension in patients with papillary thyroid carcinoma. Ann. surgical Oncol. 24(2), 460–468 (2017). https://doi.org/10.1245/s10434-016-5594-4

    Article  Google Scholar 

  12. M.J. Shim, J.L. Roh, G. Gong, K.J. Choi, J.H. Lee, S.H. Cho, S.Y. Nam, S.Y. Kim, Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma. Br. J. Surg. 100(4), 497–503 (2013). https://doi.org/10.1002/bjs.9024

    Article  CAS  PubMed  Google Scholar 

  13. G.W. Randolph, Q.Y. Duh, K.S. Heller, V.A. LiVolsi, S.J. Mandel, D.L. Steward, R.P. Tufano, R.M. Tuttle, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal, S.: The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid.: Off. J. Am. Thyroid. Assoc. 22(11), 1144–1152 (2012). https://doi.org/10.1089/thy.2012.0043

    Article  Google Scholar 

  14. B.H. Lang, T.W. Shek, A.O. Chan, C.Y. Lo, K.Y. Wan, Significance of size of persistent/recurrent central nodal disease on surgical morbidity and response to therapy in reoperative neck dissection for papillary thyroid carcinoma. Thyroid.: Off. J. Am. Thyroid. Assoc. 27(1), 67–73 (2017). https://doi.org/10.1089/thy.2016.0337

    Article  CAS  Google Scholar 

  15. C.W. Lee, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam, S.Y. Kim, Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann. surgical Oncol. 22(1), 117–124 (2015). https://doi.org/10.1245/s10434-014-3900-6

    Article  Google Scholar 

  16. S.H. Nam, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam, S.Y. Kim, Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid.: Off. J. Am. Thyroid. Assoc. 28(1), 88–95 (2018). https://doi.org/10.1089/thy.2017.0334

    Article  Google Scholar 

  17. S.H. Lee, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam, S.Y. Kim, Risk Factors for recurrence after treatment of N1b papillary thyroid carcinoma. Ann. Surg. (2018). https://doi.org/10.1097/SLA.0000000000002710

  18. E. Song, J. Ahn, D.E. Song, W.W. Kim, M.J. Jeon, T.Y. Sung, T.Y. Kim, K.W. Chung, W.B. Kim, Y.K. Shong, S.J. Hong, Y.M. Lee, W.G. Kim, Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma. Clin. Endocrinol. 92(4), 358–365 (2020). https://doi.org/10.1111/cen.14115

    Article  Google Scholar 

  19. B.H. Lang, T.W. Shek, K.Y. Wan, Impact of microscopic extra-nodal extension (ENE) on locoregional recurrence following curative surgery for papillary thyroid carcinoma. J. Surgical Oncol. 113(5), 526–531 (2016). https://doi.org/10.1002/jso.24180

    Article  CAS  Google Scholar 

  20. N. Chereau, C. Buffet, C. Tresallet, F. Tissier, L. Leenhardt, F. Menegaux, Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management. Surgery 159(3), 755–762 (2016). https://doi.org/10.1016/j.surg.2015.08.033

    Article  PubMed  Google Scholar 

  21. M.L. Urken, G.C. Haser, I. Likhterov, B.M. Wenig, The impact of metastatic lymph nodes on risk stratification in differentiated thyroid cancer: have we reached a higher level of understanding? Thyroid.: Off. J. Am. Thyroid. Assoc. 26(4), 481–488 (2016). https://doi.org/10.1089/thy.2015.0544

    Article  Google Scholar 

  22. M.H. Wu, W.T. Shen, J. Gosnell, Q.Y. Duh, Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Head. Neck 37(9), 1336–1343 (2015). https://doi.org/10.1002/hed.23747

    Article  PubMed  Google Scholar 

  23. Y. Ito, T. Kudo, K. Kobayashi, A. Miya, K. Ichihara, A. Miyauchi, Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J. Surg. 36(6), 1274–1278 (2012). https://doi.org/10.1007/s00268-012-1423-5

    Article  PubMed  Google Scholar 

  24. Y.M. Lee, J.W. Cho, S.J. Hong, J.H. Yoon, Dynamic risk stratification in papillary thyroid carcinoma measuring 1 to 4 cm. J. surgical Oncol. 118(4), 636–643 (2018). https://doi.org/10.1002/jso.25182

    Article  Google Scholar 

  25. M. Lango, D. Flieder, R. Arrangoiz, C. Veloski, J.Q. Yu, T. Li, B. Burtness, R. Mehra, T. Galloway, J.A. Ridge, Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid.: Off. J. Am. Thyroid. Assoc. 23(9), 1099–1105 (2013). https://doi.org/10.1089/thy.2013.0027

    Article  CAS  Google Scholar 

  26. Y. Ito, A. Miyauchi, H. Masuoka, T. Higashiyama, M. Kihara, A. Miya, Prognostic value of extranodal tumor extension in papillary thyroid carcinoma: proposal for upstaging of cases with extranodal tumor extension. World J. Surg. 44(2), 638–643 (2020). https://doi.org/10.1007/s00268-019-05232-3

    Article  PubMed  Google Scholar 

  27. A.K. Leite, M.A. Kulcsar, B. de Godoi Cavalheiro, E.S. de Mello, V.A. Alves, C.R. Cernea, L.L. Matos, Death related to pulmonary metastasis in patients with differentiated thyroid cancer. Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 23(1), 72–78 (2017). https://doi.org/10.4158/ep161431.or

    Article  Google Scholar 

  28. M. Kim, W.G. Kim, S. Park, H. Kwon, M.J. Jeon, J.J. Lee, J.S. Ryu, T.Y. Kim, Y.K. Shong, W.B. Kim, Initial size of metastatic lesions is best prognostic factor in patients with metastatic differentiated thyroid carcinoma confined to the lung. Thyroid.: Off. J. Am. Thyroid. Assoc. 27(1), 49–58 (2017). https://doi.org/10.1089/thy.2016.0347

    Article  CAS  Google Scholar 

  29. Y.M. Lee, T.Y. Sung, W.B. Kim, K.W. Chung, J.H. Yoon, S.J. Hong, Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection. Br. J. Surg. 103(8), 1020–1025 (2016). https://doi.org/10.1002/bjs.10144

    Article  CAS  PubMed  Google Scholar 

  30. M.J. Jeon, W.G. Kim, Y.M. Choi, H. Kwon, Y.M. Lee, T.Y. Sung, J.H. Yoon, K.W. Chung, S.J. Hong, T.Y. Kim, Y.K. Shong, D.E. Song, W.B. Kim, Features predictive of distant metastasis in papillary thyroid microcarcinomas. Thyroid.: Off. J. Am. Thyroid. Assoc. 26(1), 161–168 (2016). https://doi.org/10.1089/thy.2015.0375

    Article  Google Scholar 

Download references

Funding

This study was funded by Henan Health Commission (Grant No. 2018020490).

Author information

Authors and Affiliations

Authors

Contributions

H.H. and J.W.Q. designed research; H.H., W.B.G., and C.Z. conducted research; H.H. and B.Z. analyzed data; H.H. wrote the paper; J.W.Q. had primary responsibility for final content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jianwu Qin.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval and consent to participate

The study was reviewed and approved by Institutional Review Board of the Affiliated Cancer Hospital of Zhengzhou University. This study was conducted in accordance with the Declaration of Helsinki.

Consent for publication

All authors have reviewed the final version of the manuscript and are in agreement its content and submission.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hei, H., Gong, W., Zheng, C. et al. Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer. Endocrine 77, 73–79 (2022). https://doi.org/10.1007/s12020-022-03045-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03045-4

Keywords

Navigation